Metformin × inflammation & biomarkers

TrialPsychoneuroendocrinology2016

Testosterone and depressive symptoms among men in the Diabetes Prevention Program.

Catherine Kim et al.PubMed ↗Full text ↗Publisher ↗

  • Metforminno clear effectLower testosterone increases, no range given.No ranges given.

What the trial testedas reported · 886 people · 2016

No range given

Reported lower testosterone increases, no range given

−0.12

metformin vs placebo

As reported

difference −0.12, no interval

Who was studied, and how

886people with type 2 diabetes, in this paper

The trial randomly assignedassigned by chance

metformin
placebo

Reported lower testosterone increases, no range given−0.12

randomised

the abstract, start to end

metformin vs. placebo (1.15nmol/l vs. -0.12nmol/l vs. -0.27nmol/l,

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Testosterone increasesmetformin vs placebo
−0.12
MetforminInflammation & biomarkers
1 / 4

9 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27371769